Evidence map›Paper›PMID 41491287›Full record

ArticleEuropean journal of medical research2026

Prediction of menstrual patterns and analysis of adverse effects for hysteroscopic endometrial polypectomy combined with LNG-IUS treatment: a single-center retrospective cohort study.

Ruikun Zhao, Yinan Chen, Ping Lu, Yuanyuan Hu, Quanjia Jiang, Qin Zhou

Abstract read
In one paragraph

Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruikun ZhaoDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Yinan ChenDepartment of Mathematics, School of Mathematics and Physics, University College London, London, WC1E 6AE, UK.
Ping LuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Yuanyuan HuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
Quanjia JiangDepartment of Obstetrics and Gynecology, Chongqing Shapingba Maternity and Child Healthcare Hospital, Shapingba District, Chongqing, 401331, China.
Qin ZhouDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China. zhqinou@hospital.cqmu.edu.cn.ORCID http://orcid.org/0000-0001-6306-6419

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to analyze the clinical data within one year of the patients who underwent hysteroscopic endometrial polypectomy with levonorgestrel-releasing intrauterine system (LNG-IUS) insertion, and to identify the risk factors affecting the duration of irregular uterine bleeding pattern (IUBP), trying to build models predicting this period and evaluate the performance of the models, in order to shorten the IUBP duration through intervention.

methodsClinical data were collected from 245 patients who underwent hysteroscopic endometrial polypectomy and LNG-IUS placement at our hospital between January 2018 and December 2022. The data, recorded within one year after LNG-IUS insertion, included age, the number of polyps, preoperative endometrial thickness, maximum polyp diameter, the timing of LNG-IUS placement, LNG-IUS expulsion and migration, coital bleeding, pelvic pain, amenorrhea, irregular uterine bleeding pattern, and polyp recurrence. The differences of adverse reactions were analyzed by age and LNG-IUS placement timing stratified. Logistic regression model and Generalized Additive Model (GAM) were established to predict the duration of irregular uterine bleeding after LNG-IUS insertion, and attempts were made to explore the relationship between the variables.

resultsAge was the independent risk factor for amenorrhea after LNG-IUS insertion, the patients with aged ≥ 40 years were more likely to experience amenorrhea (P < 0.05). No significant difference was observed between patients who had LNG-IUS placement at surgery immediately and those who had LNG-IUS placement within 3 months postoperatively regarding the incidence of adverse reactions. Preoperative endometrial thickness and maximum polyp diameter were the independent risk factors for the duration of irregular uterine bleeding after LNG-IUS insertion. Comprised preoperative endometrial thickness and maximum polyp diameter identified using logistic regression model and GAM model could predict the duration of IUBP effectively. The tenfold cross-validation showed that the GAM model (AUC 0.906) had slightly better predictive power than the bivariate logistic regression model (AUC 0.902).

conclusionsHysteroscopic polypectomy combined with LNG-IUS insertion was an effective measure to treat endometrial polyps. LNG-IUS intraoperative placement did not increase the incidence of adverse reactions. Preoperative endometrial thickness and maximum polyp diameter play a key role in valuable prediction for the duration of irregular uterine bleeding after LNG-IUS insertion.

Indexed as

HysteroscopyIntrauterine Devices, MedicatedLevonorgestrelPolypsAdultEndometriumFemaleHumansMiddle AgedRetrospective StudiesRisk FactorsLevonorgestrelAdverse effectAmenorrheaEndometrial polypGeneralized Additive Model (GAM)Irregular Uterine Bleeding Pattern (IUBP)Levonorgestrel-releasing Intrauterine System (LNG-IUS)Placement timing

Identifiers

PMID41491287
PMCPMC12870506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.